Literature DB >> 26384793

Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy.

Caitlin W Hicks1, Jeffrey J Tosoian1, Rebecca Craig-Schapiro1, Vicente Valero1, John L Cameron1, Frederic E Eckhauser1, Kenzo Hirose1, Martin A Makary1, Timothy M Pawlik1, Nita Ahuja1, Matthew J Weiss1, Christopher L Wolfgang2.   

Abstract

BACKGROUND: The purpose of this study was to investigate the prognostic significance of early (30-day) hospital readmission (EHR) on mortality after pancreatectomy.
METHODS: Using a prospectively collected institutional database linked with a statewide dataset, we evaluated the association between EHR and overall mortality in all patients undergoing pancreatectomy at our tertiary institution (2005 to 2010).
RESULTS: Of 595 pancreatectomy patients, EHR occurred in 21.5%. Overall mortality was 29.4% (median follow-up 22.7 months). Patients with EHR had decreased survival compared with those who were not readmitted (P = .011). On multivariate analysis adjusting for baseline group differences, EHR for gastrointestinal-related complications was a significant independent predictor of mortality (hazard ratio 2.30, P = .001).
CONCLUSIONS: In addition to known risk factors, 30-day readmission for gastrointestinal-related complications following pancreatectomy independently predicts increased mortality. Additional studies are necessary to identify surgical, medical, and social factors contributing to EHR, as well as interventions aimed at decreasing postpancreatectomy morbidity and mortality.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mortality; Outcomes; Pancreatectomy; Readmission

Mesh:

Year:  2015        PMID: 26384793      PMCID: PMC4634566          DOI: 10.1016/j.amjsurg.2015.05.009

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  23 in total

1.  Can routine preoperative data predict adverse outcomes in the elderly? Development and validation of a simple risk model incorporating a chart-derived frailty score.

Authors:  Levana G Amrock; Mark D Neuman; Hung-Mo Lin; Stacie Deiner
Journal:  J Am Coll Surg       Date:  2014-06-03       Impact factor: 6.113

2.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

Review 3.  The prevalence and outcomes of frailty in older cancer patients: a systematic review.

Authors:  C Handforth; A Clegg; C Young; S Simpkins; M T Seymour; P J Selby; J Young
Journal:  Ann Oncol       Date:  2014-11-17       Impact factor: 32.976

4.  A novel risk scoring system reliably predicts readmission after pancreatectomy.

Authors:  Vicente Valero; Joshua C Grimm; Arman Kilic; Russell L Lewis; Jeffrey J Tosoian; Jin He; James F Griffin; John L Cameron; Matthew J Weiss; Charles M Vollmer; Christopher L Wolfgang
Journal:  J Am Coll Surg       Date:  2015-01-08       Impact factor: 6.113

Review 5.  Complications of pancreatic cancer resection.

Authors:  C M Halloran; P Ghaneh; L Bosonnet; M N Hartley; R Sutton; J P Neoptolemos
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

6.  Tracking early readmission after pancreatectomy to index and nonindex institutions: a more accurate assessment of readmission.

Authors:  Jeffrey J Tosoian; Caitlin W Hicks; John L Cameron; Vicente Valero; Frederic E Eckhauser; Kenzo Hirose; Martin A Makary; Timothy M Pawlik; Nita Ahuja; Matthew J Weiss; Christopher L Wolfgang
Journal:  JAMA Surg       Date:  2015-02       Impact factor: 14.766

Review 7.  Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials.

Authors:  Aaron L Leppin; Michael R Gionfriddo; Maya Kessler; Juan Pablo Brito; Frances S Mair; Katie Gallacher; Zhen Wang; Patricia J Erwin; Tanya Sylvester; Kasey Boehmer; Henry H Ting; M Hassan Murad; Nathan D Shippee; Victor M Montori
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

8.  Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

9.  Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal.

Authors:  Irina Yermilov; David Bentrem; Evan Sekeris; Sushma Jain; Melinda A Maggard; Clifford Y Ko; James S Tomlinson
Journal:  Ann Surg Oncol       Date:  2008-11-11       Impact factor: 5.344

10.  Readmission after pancreatectomy for pancreatic cancer in Medicare patients.

Authors:  Deepthi M Reddy; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin; Taylor S Riall
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

View more
  4 in total

1.  Mortality and Graft Loss Attributable to Readmission After Kidney Transplantation: Immediate and Long-term Risk.

Authors:  Elizabeth A King; Mary Grace Bowring; Allan B Massie; Lauren M Kucirka; Mara A McAdams-DeMarco; Fawaz Al-Ammary; Niraj M Desai; Dorry L Segev
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

2.  A National Assessment of Optimal Oncologic Surgery for Distal Pancreatic Adenocarcinomas.

Authors:  Katherine Hrebinko; Samer Tohme; Richard S Hoehn; Samer AlMasri; Sidrah Khan; Christof Kaltenmeier; Kenneth K Lee; Alessandro Paniccia; Amer Zureikat; Ibrahim Nassour
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.327

3.  Effect of Enhanced Recovery After Surgery program on hospital stay and 90-day readmission after pancreaticoduodenectomy: a single, tertiary center experience in Korea.

Authors:  Doo-Hun Kim; Yoo-Seok Yoon; Ho-Seong Han; Jai-Young Cho; Jun-Seo Lee; Boram Lee
Journal:  Ann Surg Treat Res       Date:  2021-02-01       Impact factor: 1.859

4.  Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.

Authors:  Jason P Burnham; Jennie H Kwon; Margaret A Olsen; Hilary M Babcock; Marin H Kollef
Journal:  Infect Control Hosp Epidemiol       Date:  2017-12-17       Impact factor: 3.254

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.